Form D · Venture Capital Fund
Alpine ImmunoSciences, L.P.
Seattle, WA · CIK 0001628571
Offering snapshot reported Dec 24, 2014 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 24, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund, Other
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-230869
Limited Partner Interests
Source: Form D, filed Dec 24, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Alpine Bio Ventures, Gp, Llc | Executive |
| Mitchell Gold | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
600 Stewart Street, Suite 1503
Seattle, WA, 98101
Seattle, WA, 98101